Scott D. Rowley, MD

Professor
Georgetown University School of Medicine

Disclosure(s): COTA: Stocks/Bonds (Private Company); Genetic Testing Cooperative: Stocks/Bonds (Private Company); SirPant Immunotherapeutics: Advisor/Consultant

Poster(s):

• (P-2320) Clinical Significance of Colonization with Fluoroquinolone-Resistant Enterobacterales in Hematopoietic Cell Transplant Recipients and Patients with Acute Leukemia
  Saturday, October 19, 2024

  12:15 PM – 1:30 PM US PT